Influence of polymeric additives on the cohesion and mechanical properties of calcium phosphate cements by unknown
BIOMATERIALS SYNTHESIS AND CHARACTERIZATION Original Research
Influence of polymeric additives on the cohesion and mechanical
properties of calcium phosphate cements
Jie An1 • Joop G. C. Wolke1 • John A. Jansen1 • Sander C. G. Leeuwenburgh1
Received: 21 August 2015 / Accepted: 5 January 2016 / Published online: 19 January 2016
 The Author(s) 2016. This article is published with open access at Springerlink.com
Abstract To expand the clinical applicability of calcium
phosphate cements (CPCs) to load-bearing anatomical
sites, the mechanical and setting properties of CPCs need
to be improved. Specifically, organic additives need to be
developed that can overcome the disintegration and brit-
tleness of CPCs. Hence, we compared two conventional
polymeric additives (i.e. carboxylmethylcellulose (CMC)
and hyaluronan (HA)) with a novel organic additive that
was designed to bind to calcium phosphate, i.e. hyaluro-
nan–bisphosphonate (HABP). The unmodified cement used
in this study consisted of a powder phase of a-tricalcium
phosphate (a-TCP) and liquid phase of 4 % NaH2PO4-
2H2O, while the modified cements were fabricated by
adding 0.75 or 1.5 wt% of the polymeric additive to the
cement. The cohesion of a-TCP was improved consider-
ably by the addition of CMC and HABP. None of the
additives improved the compression and bending strength
of the cements, but the addition of 0.75 % HABP resulted
into a significantly increased cement toughness as com-
pared to the other experimental groups. The stimulatory
effects of HABP on the cohesion and toughness of the
cements is hypothesized to derive from the strong affinity
between the polymer-grafted bisphosphonate ligands and
the calcium ions in the cement matrix.
1 Introduction
Calcium phosphates (CaPs) have been extensively applied
in dentistry, orthopedics and reconstructive surgery due to
their excellent bone response [1]. CaPs are commercially
available as pre-fabricated blocks and granules, which are
difficult to handle from a clinical point of view. For
example, CaP granules can migrate or dislocate easily into
the surrounding tissue [2, 3]. Consequently, calcium
phosphate cements (CPCs) have been widely investigated
in view of their favorable handling properties. The self-
hardening capacity of CPCs provides the possibility to
fully adapt the bone substitute to the shape of the bone
defect.
However, the risks associated with the use of CPCs as
bone substitutes are related to the disintegration and the
brittleness of CPCs. For example, premature disintegration
can result in inflammatory responses [4]. In addition, these
disintegrated cement particles may leak into the tissues
surrounding the defect area, causing side effects such as
nerve pain, venous and pulmonary embolism [5].
Concerning the brittleness of CPCs, it was shown pre-
viously that the flexural strength of CPC is low compared
to bone, thereby limiting the applicability of CPCs to non-
load-bearing anatomical sites [6]. To broaden the applica-
tion of CPC to load-bearing applications such as spinal
fusion [7], a toughened CPC with an increased fracture
toughness needs to be developed. Several strategies can be
used to overcome these drawbacks of CPCs. For example,
by tuning the microstructural features of the precursor
powders, the mechanical properties of the resulting CPCs
can be optimized. Moreover, the chemical composition of
the cement liquid and powder as well as the liquid to
powder ratio of the substitute play an important role [8, 9].
However, the most common approach to reduce the
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brittleness of CPC for load-bearing applications involves
the modification of the cement liquid with polymeric
additives including discrete fibers or continuous networks
[10, 11]. To this end, numerous polymeric additives have
been explored, such as collagen, carboxylmethylcellulose
(CMC) and hyaluronan (HA) [10, 12–14]. CMC is a
commonly used additive in surgical applications due to its
non-toxicity and biocompatibility [15]. The carboxyl group
of this polymer provides the possibility to form electro-
static interactions with calcium ions in the CPC matrix
[16]. Similarly, the carboxyl groups in HA allow for the
formation of bonds with calcium ions in the CPC matrix.
However, these electrostatic bonds are relatively weak and
non-specific. Bisphosphonate (BP) drugs, on the other
hand, display a very strong and specific affinity for calcium
ions in the mineral phase of bone [17]. Recent insights on
the interaction between bisphosphonates and precipitated
nanocrystalline apatite surfaces indicated that the binding
between bisphosphonate and calcium ions induces proto-
nation and subsequent solubilization of orthophosphate
ions from the apatite surface [18]. It was concluded that
bisphosphonates not only complex with calcium ions, but
also replace orthophosphate ions from apatitic surfaces,
thereby ensuring a tight interaction with crystalline solids.
Previously, HA was derivatized with BP ligands to
render HA calcium-binding. Previous results confirmed
that this hyaluronan–bisphosphonate polymer (HABP)
formed strong bonds with CaP nanoparticles both in vitro
and in vivo [19]. Hence, we hypothesized that the covalent
attachment of bisphosphonate groups to the polymer
backbone of hyaluronan could improve the affinity of HA
to the cement matrix, thereby improving the cohesion and
mechanical properties of the resulting CPC. In order to
evaluate the effects of this calcium-binding polymeric
additive on the handling properties and mechanical prop-
erties of CPC, we compared this novel bisphosphonate-
functionalized hyaluronan with two conventional, unmod-
ified cohesion promoters, i.e., CMC and HA.
2 Materials and methods
2.1 Materials
Blanose sodium carboxyl methylcellulose (CMC, molecu-
lar weight 700 kDa, degree of substitution 0.88) was
obtained from Brenntag (Brenntag Nederland BV, Rotter-
dam, the Netherlands) and sieved to remove any particles
bigger than 106 lm, washed with 100 % isopropanol (an-
alytical grade, Merck, Darmstadt, Germany) to remove
potential microbiological contamination and dried at 90 C
overnight. Alpha-tricalcium phosphate (a-TCP) was pro-
vided by CAM Bioceramics BV (Leiden, The Nether-
lands). Sodium phosphate monobasic dihydrate (NaH2-
PO42H2O, Merck, Darmstadt, Germany) was used to
form the basic liquid phase of the cement formulation.
Hyaluronic acid (HA, molecular weight: 100–150 KDa)
was purchased from Lifecore Biomedical (Chaska, The
U.S.A),
2.2 Methods
2.2.1 Synthesis and characterization of hyaluronan–
bisphosphonate
Hyaluronan–thiol was synthesized according to a previ-
ously established protocol [19] and further functionalized
with bisphosphonate via thiol–ene photopolymerization.
To this end, various amounts of acrylated bisphosphonate
(synthesized as described previously [20]) were added to
400 mg of hyaluronan–thiol in 80 ml degassed Milli-Q
water in order to obtain bisphosphonate-to-thiol molar
ratios of 4:1. Subsequently, 8 mg of Irgacure 2959 was
added and the mixture was stirred for 10 min under ultra-
violet light (36 W UV timer lamp, CNC international BV,
The Netherlands). Thereafter, the mixture was dialyzed
against 0.1 M NaCl at pH 3.5 (molecular weight cutoff of
3.5 kDa) and subsequently dialyzed twice against milli-Q
water at pH 3.5. The solution was neutralized to pH 7.4 and
lyophilized. The chemical composition of the polymer was
confirmed using NMR [19].
2.2.2 CPC preparation
In total 7 CPC formulations were prepared at a fixed liquid
to powder (L/P) ratio of 0.5 for all formulations. For the
polymer-free CPC, 500 ll of a 4 w/v % NaH2PO42H2O
aqueous solution was added to 1 g of a-TCP powder inside
a 2 ml plastic syringe (Kendall monoject, Gosport, UK),
sealed with a closed tip and shaken for 25 s (Silamat
mixing apparatus, Vivadent, Schaan, Liechtenstein). For-
mulations containing CMC were prepared by adding either
0.0075 g (0.75 wt%) or 0.015 g (1.5 wt%) of CMC powder
to 0.9925 and 0.985 g of a-TCP powder, respectively, after
which the powder mixture was shaken for 25 s in the Sil-
amat mixing apparatus. Subsequently, 500 ll of a 4 %
w/v NaH2PO42H2O solution was added to each syringe
which was mixed vigorously for 25 s again using the Sil-
amat mixing apparatus. For HA- and HABP-containing
formulations, 0.0075 g (0.75 wt%) or 0.015 g (1.5 wt%) of
each additive was dissolved in the liquid phase (4 % w/v
aqueous solution of NaH2PO42H2O) prior to mixing
500 ll of the liquid phase to 1 g of a-TCP and shaking for
25 s in the Silamat mixer.
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2.2.3 Setting time test
The initial and final setting time of the cement was assessed
using Gillmore needles (ASTM, 1999). A bronze block was
used as mould containing 6 holes (6 mm in diameter,
12 mm in height). The mould was placed in a water bath at
body temperature (37 C). All formulations were tested in
threefold.
2.2.4 Cohesion test
The cohesion of the calcium phosphate paste was first
evaluated qualitatively. Briefly, CPC paste was formed
after mixing the contents for 25 s (Silamat Mixing
apparatus; Vivadent). Subsequently, 1 g of each paste was
injected into a 6 well culture plate containing 10 ml milli-
Q water per well. All pastes were left for hardening in the
well at room temperature for 4 h, after which the cohesion
of the cements was recorded qualitatively using
photographs.
Secondly, a method was developed to test the cohesion
of the calcium phosphate paste quantitatively. To this end,
a polytetrafluorethylene (PTFE) mold was designed con-
taining a circular hole of 6 mm in diameter. After 25 s of
mixing, seven composites were injected into seven separate
PTFE molds, respectively. Subsequently, the surfaces of
CPCs in the mold were smoothened and the molds con-
taining the hardening CPCs were incubated in 10 ml of
milli-Q water for 4 h at room temperature. The total han-
dling time was fixed at 1 min including 25 s of mixing
time. After 4 h of soaking, the PTFE mold was removed
from the water, the supernatant was discarded, after which
the sediment was freeze-dried and weighed. The quantita-
tive evaluation of the wash-out was determined (n = 5)
using the following equation:
Wash-outð%Þ ¼ weight of sediment
original weight of cement
 100% ð1Þ
2.2.5 Mechanical properties
After mixing, the pastes were injected into a PTFE mold
(cylinder shaped, diameter = 4.5 mm, height = 9 mm) to
obtain cylindrical-shaped samples. Setting of the cement
was performed within the mold at 100 % relative humidity
for 24 h [21]. After soaking in Phosphate Buffered Saline
(PBS) for 7 days, samples were placed in a tensile bench
(858 MiniBionix2, MTS Corp., Eden Prairie, MN, USA).
The compressive strength of the samples was measured at a
crosshead speed of 0.5 mm/min using a load cell of 2.5 kN.
Rectangular samples were produced (3 9 4 9 25 mm)
in order to perform three-point bending tests [22]. After
soaking the samples in PBS for 7 days, this three-point
bending test was performed on a mechanical test bench at a
cross-head speed of 0.5 mm/min using a load cell of 0.5
kN. Before testing, the samples were polished on one of
their 4 9 25 mm2 surfaces using silicon carbide paper with
grits of 1200. After fracture, the maximum load on the
testing specimen was recorded and the bending strength of
samples was calculated using Eq. 2 [23]:
Bending strength ¼ 3PmaxL
2bh2
ð2Þ
where Pmax is the maximum load on the load–displacement
curve, L is the length of the support span, b is the specimen
width and h is the specimen thickness (n = 5). Afterwards,
the representative three-point bending load–displacement
curves of both unmodified and polymer-modified CPC
samples were recorded and the areas below the curves were
divided by the specimen cross-section (bh) to obtain a
quantitative measure for the toughness (in terms of work of
fracture) of the samples. The test was stopped at a maxi-
mum crosshead displacement of 2 mm to allow for com-
parison between all experimental groups.
2.2.6 XRD
After the mechanical tests, solid samples were grinded to
powder and powder X-ray diffraction (XRD, Philips, PW
3710, Almelo, the Netherlands) was applied to determine
the crystal phases of the cement composites.
2.2.7 SEM
The fracture surfaces after the bending tests were collected
for morphological analysis using scanning electron
microscopy (SEM, JEOL6340F, Tokyo, Japan, operated at
10 kV and a working distance = 15 mm).
2.3 Statistical analysis
Data were presented as mean ± standard deviation. Sig-
nificant differences were determined using one-way anal-
ysis of variance (One-way ANOVA) followed by a Tukey
post hoc test. Results were considered significant if
P\ 0.05. Calculations were performed using GraphPad
Instat (GraphPad Software Inc., San Diego, CA, USA).
3 Results
3.1 Setting time of CPCs
The initial setting time of a-TCP was 2 min and the final
setting time was 4.8 ± 1.2 min (Fig. 1). All polymeric
additives delayed the initial setting time of the CPCs, but
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the addition of CMC resulted into the most pronounced
delaying effect on the initial (4.5 ± 0.5 min for 0.75 %
CMC and 4.9 ± 0.8 min for 1.5 % CMC) and final setting
times (8.9 ± 0.6 min for 0.75 % CMC and 8.9 ± 1 min
for 1.5 % CMC). The addition of HA, on the other hand,
resulted into a minor delaying effect on the initial
(2.8 ± 0.2 min for 0.75 % HA and 3.5 ± 0.5 min for
1.5 % HA) and final setting times (4.6 ± 0.4 min for
0.75 % HA and 6.6 ± 0.5 min for 1.5 % HA). The initial
setting times of CPCs containing 0.75 % HABP and 1.5 %
HABP groups were comparable (3 ± 0.5 min and
3.2 ± 0.2 min, respectively), whereas the final setting of
the CPC containing the highest amount of HABP (1.5 %)
was longer (7 ± 0.5 min) compared to the group with the
lower amount (0.75 %) of HABP (5.4 ± 0.3 min).
3.2 Cohesion
A qualitative impression of the cohesion of the cements is
shown in Fig. 2. Monophasic a-TCP-based cement disinte-
grated into small pieces surrounded by a cloudy supernatant
after 4 h of soaking. Cements containing 0.75 % CMC
showed a stable and curved wire-like shape after injection.
However, the shape of 1.5 % CMC group expanded during
soaking resulting in an increased thickness of the wire-like
shape and a cloudy supernatant. Both 0.75 % HA and 1.5 %
HA formulations maintained their shape after extrusion of the
CPC into water, without the presence of wire-like features
that are characteristic for cohesive formulations. Incorpora-
tion of 0.75 % HABP into CPCs resulted into stable and
straight wire-like shapes as well as minor particles, while the
cement was extruded as discrete, straight wires upon incor-
poration of 1.5 % HABP into the cement.
The quantitative evaluation of cohesion provided addi-
tional insight into the cohesion of the various formulations.
All formulations showed a significantly reduced wash-out
ratio compared to the unmodified cement control (Fig. 3).
The addition of CMC and HABP resulted into strongly
reduced wash-out ratios, whereas only a minor effect on the
wash-out ratio was observed upon addition of unfunction-
alized hyaluronan.
3.3 Mechanical properties
The compressive strength of a-TCP and CPC composites after
7 days of soaking in PBS is depicted in Fig. 4. After adding the
polymeric additives, no differences were found in compressive
strength compared to unmodified cements (10.5 ± 2.0 MPa).
However, the compressive strength of cements containing
1.5 % CMC (5.8 ± 1.3 MPa) was significantly lower com-
pared to the groups containing HA (0.75 % HA = 10.5 ±
0.9 MPa, 1.5 % HA = 10.8 ± 2.1 MPa).
The bending strength (Fig. 5) as obtained from the three-
point bending test revealed no differences between unmodi-
fied and polymer-modified modified cements, whereas a
significantly lower bending strength was obtained for cements
containing 1.5 % HABP (3.6 ± 0.7 MPa) compared to
cements containing bisphosphonate-free HA as additive
(0.75 % HA = 5.5 ± 1 MPa, 1.5 % HA = 5.5 ± 0.7 MPa).
Fig. 1 Initial (left columns) and final setting times (right columns) of
CPCs containing different amounts and types of polymeric additives
(n = 3)
Fig. 2 Disintegration of the
cements after extrusion in water
and 4 h of immersion
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Figure 6 shows representative load–displacement curves
of the three-bending tests for unmodified cements (a-TCP)
and cements containing 0.75 % of CMC, HA or HABP.
The curves indicated that unmodified CPC (a-TCP) frac-
tured in a brittle manner after reaching the peak load of the
material, after which the load-bearing capacity decreased
abruptly. A similarly sharp decrease was observed for
cements containing 0.75 % CMC or 0.75 % HA. However,
cements containing 0.75 % of HABP displayed higher
extensibility than the other groups. Figure 7 shows that the
toughness for cements containing 0.75 % HABP
(40.9 ± 10.8 J/m2) was significantly higher than unmodi-
fied cements (19.6 ± 5 J/m2, P\ 0.001) or cements con-
taining 0.75 % CMC (19.5 ± 5.3 J/m2, P\ 0.001), 1.5 %
HA (26.1 ± 1.92 J/m2, P\ 0.05) or 1.5 % HABP
(22.7 ± 8.8 J/m2, P\ 0.05).
3.4 XRD
X-ray diffraction (XRD) patterns (Fig. 8) showed that all
cements were converted to the apatite phase (main reflec-
tions indicated with black ovals) after 7 days of incubation.
No differences were observed between the various exper-
imental groups.
3.5 SEM
SEM micrographs of the fractured surfaces after three-
point bend testing were analyzed and the representative
images of a-TCP, 1.5 % CMC, 1.5 % HA and 1.5 %
HABP are shown in Fig. 9. All fracture surfaces were
rough and irregular with several micron-scale pores at the
fracture surface. Sub-micron crystals were observed on the
fracture surfaces of the cements containing 1.5 % CMC or
1.5 % HABP.
Fig. 3 Wash-out ratio of a-TCP and polymer-containing composites
after 4 h of immersion. a Significantly different compared to CMC-
containing groups (P\ 0.05), b different compared to 1.5 % HA
(P\ 0.05), c significantly different compared to HABP-containing
groups (P\ 0.05)
Fig. 4 Compressive strength of samples after 7 days in PBS,
significant differences were marked with an asterisk when P\ 0.05
Fig. 5 Bending strength of samples after 7 days in PBS, significant
differences were marked with an asterisk when P\ 0.05
Fig. 6 Representative three-point bending load–displacement curves
of unmodified cements (a-TCP) and cements containing 0.75 %
CMC, 0.75 % HA or 0.75 % HABP
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4 Discussion
The setting time of self-setting CPCs is a crucial parameter
for their clinical applicability. Since the clinical wound
area can only be closed after setting of the cement, the time
required for this hardening process is very critical. For
optimal clinical handling of CPCs, the suggested final
setting time should be below 15 min [24]. The setting
properties of cements have been modified by controlling
the particle size of calcium phosphate precursor powders,
adding a nucleating phase, or dissolving additives into the
liquid phase that accelerate or inhibit the setting reaction
[25]. The XRD analysis confirmed that after reacting with
the liquid phase, a-TCP converted into hydroxyapatite.
Previous reports indicated that organic additives can
influence this transformation process [26–28], but none of
the polymeric additives selected in the current study
impaired the transformation from a-TCP to hydroxyapatite.
The setting time of CPCs increased from 2 to 5 min for
the initial setting and from 6 to 10 min for the final setting.
The addition of the lowest amount of HA (0.75 %) did not
affect the setting of the CPCs, but the highest amount of
HA (1.5 %) resulted into a delayed setting as well. This
observation is in agreement with the research by Kai et al.
[29] who observed that setting times increased with
increasing amount of HA incorporation. Since both CMC
and HA contain pendant carboxyl groups, we speculate that
the more pronounced delaying effect of CMC on the setting
of CPC was caused by physical factors such as a higher
viscosity of CMC-containing solutions. Regarding the
effect of free or conjugated bisphosphonates, it was shown
by Panzavolta et al. that free alendronate (added to the
cement at high concentrations of about 1 mM) delayed the
initial and final setting times of CPCs to 10 and 33 min,
respectively [30]. In the current study we also observed a
delaying effect of bisphosphonate-functionalized HA on
the setting properties of CPC, albeit to a much lower
extent. This phenomenon can be explained by the fact that
the bisphosphonate concentration in the study of Panza-
volta et al. was much higher (1 mM) than in the current
study (degree of bisphosphonate-for-carboxyl substitution
of 8 % [20] at HABP contents of 0.75 and 1.5 wt% only).
Consequently, the initial and final setting times of HABP-
modified cements were still within the acceptable range for
clinical handling and workability.
CPCs are materials designed to be implanted as a paste,
which implies that the paste is in contact with blood or
other body fluids upon surgical application. The capacity of
CPCs to set in a fluid without disintegration into smaller
fragments is often referred to as ‘cohesion’. Several
approaches have been adopted to improve the cohesion of
CPCs, such as lowering the liquid to powder ratio (L/P),
decreasing the particle size of calcium phosphates, and
replacing the liquid phase with a viscous polymeric solu-
tion [31, 32]. Here, we studied the addition of several
organic additives as cohesion promoters to the cement
formulation. Direct addition of CMC to the liquid phase of
the cements resulted in highly viscous solutions, which
compromised the injectability of the cements. Therefore,
we added CMC to the powder phase (a-TCP) of the cement
formulation. In this way, the reaction time between CMC
and the liquid phase was controlled without compromising
the injectability and cohesion of the cements. The wash-out
ratio of a-TCP was decreased most effectively by the
incorporation of CMC and HABP as cohesion promoters.
CMC apparently immobilized the CPC particles, thereby
improving the washout resistance of the cement [13].
HABP acted as an effective binder by forming electrostatic
interactions between calcium ions in the CPC matrix and
Fig. 7 The toughness after the three-point bending test of unmodified
cements (a-TCP) and cements containing various amounts and types
of polymeric additives. ** indicates P\ 0.01, * indicates P\ 0.05
Fig. 8 X-ray diffraction patterns after 7 days of incubation of
unmodified cements (a-TCP) and cements containing 0.75 % CMC,
1.5 % CMC, 0.75 % HA, 1.5 % HA, 0.75 % HABP and 1.5 %
HABP. Main apatitic reflections are indicated with black ovals
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the calcium-binding bisphosphonate groups conjugated to
the HA backbone.
Generally, the brittleness of CPCs limits the long-term
performance and clinical applicability of CPCs. Recent
studies indicated that the strength and toughness of the
cements can be substantially improved by polymeric rein-
forcements, thereby providing the potential to facilitate
applications in load-bearing skeletal sites [22, 33–35]. A
large number of parameters affect the mechanical proper-
ties of these materials, such as the cement preparation and
the self-setting reaction. Previous results demonstrated that
the weak mechanical properties of CPC are mainly caused
by the inherent high porosity, while the compressive
strength of CPCs was increased considerably by lowering
the porosity into more dense microstructures [9, 36, 37].
Generally, we observed that the coefficient of variation of
both the compressive and bending strength of the cements
was large, which is typical for ceramic materials due to the
presence of surface defects and internal pores. We did not
observe any positive effect of the selected polymeric
reinforcements on the compression or bending strength,
while the compression and bending strength of the CPCs
were compromised by the addition of the highest amount
(1.5 wt%) of CMC and HABP, respectively. From SEM
observations we can conclude that sub-micron crystals
were present at the fracture surfaces of CPCs containing
1.5 % CMC or HABP, which might have introduced
nanoporosity into the cements that contributed to lower
strength values. The only polymeric additive that effec-
tively increased the cement toughness was HABP at a
concentration of 0.75 wt%. Nevertheless, it can be con-
cluded that the addition of the selected polymeric additives
resulted into pronounced effects on cement setting and
cohesion, but only marginal effects of cement strength and
toughness.
5 Conclusions
The effect of two conventional polymeric additives (i.e.
CMC and HA) on the cohesion, setting and mechanical
properties of calcium phosphate cements was compared to
a novel organic additive that was designed to bind to cal-
cium phosphate, i.e. hyaluronan–bisphosphonate (HABP).
The cohesion of a-TCP was improved considerably by the
addition of CMC and HABP. None of the additives
improved the compression and bending strengths of the
cements, but the addition of 0.75 % HABP resulted into a
significantly increased cement toughness as compared to
the other experimental groups.
Fig. 9 Scanning electron micrographs of the fracture surfaces of unmodified cements (a) or cements modified with 1.5 % CMC (b), 1.5 % HA
(c) or 1.5 % HABP (d)
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